Home › Trial NCT01320254
PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)
- Trial IDNCT01320254
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorHannover Medical School
- Enrollment93
- Start date2011-06
- ConditionsCholangiocarcinomas
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.